Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck's Novel Immunotherapy Drug Receives 'Breakthrough Therapy Designation'
Merck's Novel Immunotherapy Drug Receives 'Breakthrough Therapy Designation'
Merck's Novel Immunotherapy Drug Receives 'Breakthrough Therapy Designation'
Submitted by
admin
on May 22, 2013 - 9:35am
Source:
Seeking Alpha
News Tags:
Merck
immunotherapy
lambrolizumab
breakthrough therapies
Headline:
Merck's Novel Immunotherapy Drug Receives 'Breakthrough Therapy Designation'
Do Not Allow Advertisers to Use My Personal information
